![]() |
市場調查報告書
商品編碼
2030338
穿戴貼片市場-全球產業規模、佔有率、趨勢、機會、預測:依科技、應用、區域和競爭格局分類,2021-2031年Wearable Patches Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Connected, Regular), By Application (Monitoring, Drug Delivery, Diagnostics, Others), By Region & Competition, 2021-2031F |
||||||
全球穿戴貼片市場預計到 2031 年將達到 1,279,750,000 美元,從 2025 年的 891,020,000 美元成長,複合年成長率為 6.22%。
這些非侵入式、貼敷於皮膚的裝置旨在無縫地提供治療並持續追蹤生理指標。市場成長主要受以下因素驅動:全球慢性病盛行率不斷上升,需要持續監測;以及遠端監測工具的普及,這些工具既能改善臨床工作流程,又能提升病患舒適度。安全無線通訊技術和微型感測器的進步進一步加速了這一擴張。為了支持互聯醫療的快速發展,CHIME 的「2024 年最互聯醫療機構」調查報告顯示,87% 的醫療機構已將遠端患者監護納入其護理策略。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 891,020,000 美元 |
| 市場規模:2031年 | 1,279,750,000 美元 |
| 複合年成長率:2026-2031年 | 6.22% |
| 成長最快的細分市場 | 已連接 |
| 最大的市場 | 北美洲 |
儘管取得了這些積極進展,但全球複雜多變的法規環境仍然是市場成長的一大障礙。醫療設備核准缺乏統一標準,尤其是創新數位醫療工具的核准標準,是一個顯著的阻礙。這種監管碎片化減緩了新產品的上市速度,並增加了開發商的遵循成本。
感測器小型化和功能化的創新正顯著推動全球穿戴貼片市場的發展。透過將小型高性能感測器整合到軟性設計中,製造商能夠提供佩戴舒適且便於患者持續監測的設備。這些改進使得單一貼片即可實現多參數感測,從而可以同時追蹤體溫、呼吸頻率、心率和特定生物標記等多種生理指標。例如,Medtronic宣布將於2025年5月在歐洲市場推出Corsano多參數穿戴設備,進一步拓展其產品線。 Corsano是一款醫療認證設備,永續追蹤心電圖、無袖帶血壓、血氧飽和度、呼吸和心率等生命徵象。透過將多種功能整合到如此小巧的設備中,穿戴式貼片正從單純的追蹤工具發展成為先進的治療和診斷設備。
全球慢性病盛行率的不斷上升是推動市場擴張的另一個主要因素。慢性呼吸系統疾病、心血管疾病和糖尿病等疾病需要持續監測才能有效管理並避免嚴重併發症。穿戴式貼片為個人提供了一種在臨床環境之外持續、非侵入性地監測關鍵健康數據的方法,從而透過預防性管理來提高生活品質。國際糖尿病聯盟 (IDF) 發布的《糖尿病地圖集》(第 11 版,2025 年)凸顯了這一需求的規模,該地圖集估計,全球 20 至 79 歲的成年人中約有 5.89 億人將患有糖尿病。人們對連線健診設備的日益依賴進一步強調了對這些便利監測工具的需求。雅培公司 2026 年 1 月的財報顯示,其主要穿戴貼片產品——連續血糖監測儀——第四季的銷售額達到 20 億美元,這正是這一趨勢的一個例證。
全球各地不斷演變且錯綜複雜的法律規範對全球穿戴貼片市場的成長構成重大障礙。醫療設備核准缺乏統一標準,給開發商帶來了嚴峻挑戰,尤其是在貼片中整合新型數位健康功能方面。因應不同的法規需要投入大量精力,且合規工作往往相互重疊,導致營運成本增加,產品開發週期延長。
這些監管障礙顯著影響企業選擇創新穿戴貼片技術首發市場的地點。根據2025年歐洲醫療技術協會(MedTech Europe)的一項調查,隨著體外診斷醫療設備法規(IVDR)和醫療設備法規(MDR)的嚴格執行,領先的醫療設備製造商將歐盟作為主要上市市場的偏好降低了約33%。這項數據凸顯了複雜的合規法規如何減緩尖端醫療產品的推廣,限制穿戴式貼片的國際普及,並最終阻礙整體市場成長。
業界最顯著的變革之一是穿戴式貼片與更廣泛的行動和數位健康網路的無縫整合,這重新定義了患者資訊的收集、共用和利用方式。這項進步使得貼片記錄的生理數據能夠即時同步到遠距遠端醫療系統、電子健康記錄 (EHR) 和智慧型手機應用程式。透過提供個人健康狀況的整體情況,這種連接性使患者和醫療專業人員能夠遠端做出明智的健康決策。正如 Epic Systems 在 2026 年 1 月發布的《商業趨勢報告》中所述,已有超過 300 家使用該公司軟體的醫療機構成功地將來自穿戴式貼片等消費級醫療設備的資訊整合到其醫療流程中,從而提高了遠端監測和預防性護理的有效性。
此外,市場正日益廣泛地應用人工智慧驅動的預測分析技術來分析穿戴式貼片持續不斷的資料流,從而能夠檢測輕微的健康異常並預測醫療事件。醫療專業人員可以利用機器學習模型分析這些持續不斷的生理訊息,將醫療模式從被動治療轉向主動預防,從而避免不良的健康後果。將原始感測器數據轉化為可操作的指南,有助於早期發現感染疾病並預測慢性疾病的惡化。Astra Zeneca在2026年1月舉行的摩根大通醫療保健大會上重點介紹了這個趨勢。該公司指出,其積極將人工智慧策略融入研發流程,以最佳化藥物開發,進一步鞏固了穿戴式貼片作為智慧醫療管理先進工具的地位。
The Global Wearable Patches Market is projected to grow from USD 891.02 Million in 2025 to USD 1279.75 Million by 2031 at a 6.22% CAGR. These non-invasive, skin-adhesive devices are engineered to seamlessly deliver therapies or constantly track physiological metrics. Market growth is largely fueled by the rising worldwide incidence of chronic conditions that require continuous observation, alongside a shift toward remote monitoring tools that improve both clinical workflows and patient comfort. Progress in secure wireless communications and miniaturized sensors further accelerates this expansion. Highlighting the rapid adoption of connected healthcare, CHIME's 2024 Most Wired survey reports that 87% of healthcare organizations now incorporate remote patient monitoring into their care strategies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 891.02 Million |
| Market Size 2031 | USD 1279.75 Million |
| CAGR 2026-2031 | 6.22% |
| Fastest Growing Segment | Connected |
| Largest Market | North America |
Despite this positive trajectory, a major hurdle restricting market growth is the intricate and constantly changing regulatory environment across various global regions. The lack of unified standards for medical device approvals, especially concerning innovative digital health tools, acts as a significant obstacle. This regulatory fragmentation can stall new product introductions and drive up compliance expenses for developers.
Market Driver
Innovations in sensor miniaturization and enhanced functionality are significantly propelling the Global Wearable Patches Market forward. By integrating smaller yet highly capable sensors into flexible designs, manufacturers provide a less intrusive and highly comfortable experience that encourages patient adherence to continuous monitoring. These improvements also bring multi-parameter sensing to a single patch, allowing simultaneous tracking of various physiological metrics like temperature, respiratory rate, heart rate, and specific biomarkers. Illustrating this progress, Medtronic announced in May 2025 the European expansion of its portfolio with the Corsano multi-parameter wearable, a medically certified device that continuously tracks vital signs including ECG, cuffless blood pressure, SpO2, breathing, and heart rate. Packing multiple functions into such a small device shifts wearable patches from simple tracking tools to advanced therapeutic and diagnostic instruments.
The escalating global rate of chronic illnesses acts as another primary catalyst for market expansion. Medical conditions like chronic respiratory issues, cardiovascular diseases, and diabetes require continuous observation to properly manage the disease and avoid severe complications. Wearable patches provide an ongoing, non-invasive way for individuals to monitor essential health data away from clinical environments, thereby enhancing their overall quality of life through proactive management. Highlighting the scale of this need, the International Diabetes Federation's 2025 11th edition Diabetes Atlas indicates that roughly 589 million adults between 20 and 79 years old are affected by diabetes worldwide. The surging reliance on connected health devices further validates this need for accessible monitoring tools, as demonstrated by Abbott's January 2026 financial report, which noted a $2.0 billion fourth-quarter sales figure for their continuous glucose monitors, a primary wearable patch category.
Market Challenge
The shifting and complicated regulatory frameworks found across different global jurisdictions pose a major obstacle to the growth of the Global Wearable Patches Market. Because there is a lack of unified criteria for approving medical devices, especially concerning the new digital health features integrated into these patches, developers face severe difficulties. Dealing with disjointed regulations requires exhaustive and frequently overlapping compliance efforts, which ultimately drives up operating expenses and extends the timeline for product development.
Such regulatory hurdles heavily impact where companies choose to debut their wearable patch innovations. A 2025 MedTech Europe survey revealed that large medical device producers reduced their preference for the European Union as a primary launch market by roughly 33% after the strict enforcement of the In Vitro Diagnostic Regulation and Medical Device Regulation. This statistic underscores the extent to which intricate compliance rules can postpone the rollout of modern healthcare products, limit the international reach of wearable patches, and ultimately stifle the broader market's expansion.
Market Trends
A prominent shift in the industry involves the smooth incorporation of wearable patches into wider mobile and digital health networks, redefining the collection, sharing, and application of patient information. This development allows physiological data recorded by the patches to sync instantly with telehealth systems, electronic health records (EHRs), and smartphone apps. By offering a complete picture of an individual's well-being, this connectivity enables both patients and medical professionals to make well-informed health choices from a distance. As noted in a January 2026 corporate update from Epic Systems, more than 300 healthcare groups using their software have successfully merged information from consumer health devices, such as wearable patches, into their medical processes to boost remote monitoring effectiveness and proactive treatment.
Additionally, the market is experiencing a strong push toward utilizing AI-powered predictive analytics to analyze the uninterrupted flow of data from wearable patches, helping to spot minor health anomalies and anticipate medical events. Healthcare professionals can use machine learning models on this constant stream of physiological information to move away from reactive responses toward preventative care, thereby avoiding negative health consequences. Converting raw sensor metrics into practical guidance allows for the early detection of infections or the prediction of chronic disease flare-ups. AstraZeneca emphasized this movement during their January 2026 presentation at the J.P. Morgan Healthcare Conference, highlighting that their research and development approach heavily incorporates AI strategies to optimize drug creation, further cementing wearable patches as sophisticated instruments for smart healthcare management.
Report Scope
In this report, the Global Wearable Patches Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Wearable Patches Market .
Global Wearable Patches Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: